Life Technologies Announces Fourth Quarter and Fiscal 2012 Results
Tuesday, February 12, 2013
Fourth quarter revenue increased 3% to $999 million, or 4.5% excluding currency.
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Products
Tuesday, February 12, 2013
Life's Applied Biosystems Dx Genetic Analyzer and SeCore® kits constitute first sequence-based system cleared for HLA typing.
Cellmid Signs Midkine Diagnostic Agreement
Monday, February 11, 2013
Multiple cancer diagnostic products are expected to be developed.
Bringing NGS to the Clinic: What Can We Expect?
Thursday, February 07, 2013
Dr Elaine Mardis shares her views with IDT on the future of NGS and its role in personalized medicine.
Anagnostics Boosts Sales Force
Tuesday, February 05, 2013
Karl Winkler takes responsibility for direct sales at Anagnostics Bioanalysis.
OBN Co-Founds and Subscribes to EDCA
Tuesday, February 05, 2013
Company takes this step in support of its diagnostics member companies.
Selventa Developing Powerful New Class of Multi-omic Based Diagnostic Test
Friday, February 01, 2013
This powerful new class of diagnostic test will accelerate the implementation of personalized healthcare.
A*STAR's GIS Collaborates with GSK to Further Research on Lung Cancer
Thursday, January 31, 2013
Partnership will advance both organizations' joint efforts towards finding a cure for the disease.
Walgreens Take Care Health Systems and Community Health Network Announce Clinical Collaboration Agreement
Thursday, January 31, 2013
Relationship creates Central Indiana’s first fully integrated and coordinated clinical care program between preeminent health care system and retail clinic provider.
|
|
|
|
|
|
